Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Shares Outstanding: 2023-2025

Historic Shares Outstanding for CG Oncology (CGON) over the last 3 years, with Sep 2025 value amounting to $78.3 million.

  • CG Oncology's Shares Outstanding rose 15.90% to $78.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.3 million, marking a year-over-year increase of 15.90%. This contributed to the annual value of $76.2 million for FY2024, which is 1358.27% up from last year.
  • CG Oncology's Shares Outstanding amounted to $78.3 million in Q3 2025, which was up 2.68% from $76.2 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Shares Outstanding ranged from a high of $78.3 million in Q3 2025 and a low of $3.9 million during Q1 2023.
  • Moreover, its 3-year median value for Shares Outstanding was $66.7 million (2024), whereas its average is $47.8 million.
  • Data for CG Oncology's Shares Outstanding shows a peak YoY spiked of 1,627.96% (in 2024) over the last 5 years.
  • Over the past 3 years, CG Oncology's Shares Outstanding (Quarterly) stood at $5.2 million in 2023, then surged by 1,358.27% to $76.2 million in 2024, then grew by 15.90% to $78.3 million in 2025.
  • Its Shares Outstanding was $78.3 million in Q3 2025, compared to $76.2 million in Q2 2025 and $76.2 million in Q1 2025.